한국비엔씨 Stock: price and insider trades · South Korea
No insider purchase over the last 90 days. The latest, by 최완규, was filed 29 Jun 2026.
한국비엔씨: what insiders have been doing
This page follows insider dealings at 한국비엔씨 as filed with DART (FSS), a company from the Health Care sector. From 2 November 2025 to 2 November 2026, the disclosure feed for 한국비엔씨 logged 6 filings by 3 insiders.
No insider sold shares on the market over the period. Instead, the filings list 2 purchases, made by 2 insiders. The amount is not disclosed for 2 filings. Unlike grants, an open-market purchase is paid for by the insider, at the market price. On the buying side, the filings list 1 major shareholder and 1 senior executive among the declarants.
The most recent open-market purchase was published on 29 June 2026, 132 days ago.
For context, the typical company on the same exchange (median of 2,655 companies) published 7 filings over the same period, against 6 filings here. Our records for 한국비엔씨 go back to 2021, with 8 purchases and no sales on the open market in total.
Other companies in the same sector with recent insider buying flagged by our signals: Dynavox Group AB and UCB. These figures are compiled from regulatory filings published by DART (FSS). They describe what insiders did and are not a recommendation.
Who traded when
BuySaleSince the insiders bought
- -76.8%Entry ₩17,400 · Close at T+365 ₩4,035
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- Other0DART
- ●Executives0DART
- 10,000 sharesKRXDART:20260629000503Canonical exit: 27 Sept 2026 (T+90)
- 10,000 sharesShareKRXDART:20260629000496Canonical exit: 27 Sept 2026 (T+90)
- 0KRXDART:20260327000762
- ●Executives0DART
- ●Executives0DART
- ●Executives0DART
- ●Executives0DART
- ●Executives0DART
- ●Executives0DART
- ●Executives0DART
- 5,000 sharesShareKRXDART:20241031000480Canonical exit: 29 Jan 2025 (T+90)
- 5,000 sharesShareKRXDART:20241031000475Canonical exit: 29 Jan 2025 (T+90)
- 20,000 sharesKRXDART:20241031000528Canonical exit: 22 Jan 2025 (T+90)
- 5,000 sharesShareKRXDART:20241031000505Canonical exit: 29 Jan 2025 (T+90)
- 5,000 sharesShareKRXDART:20241031000503Canonical exit: 29 Jan 2025 (T+90)
- 0KRXDART:20241011000578
- 0KRXDART:20240712000476
- ●Executives0DART
- ●Executives0DART
- 0KRXDART:20231128000975
- 0KRXDART:20231017000308
- 0KRXDART:20230718000350
- 0KRXDART:20230703000367
25 of 44 declarations
About 한국비엔씨
한국비엔씨 is a company operating in the healthcare and pharmaceutical sector, listed on the XKRX market. It specializes in the development and commercialization of pharmaceutical products.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
